1952 Everest Medicines Ltd. HKEX · China

Everest Medicines (1952) news

Everest Medicines Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1952, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Everest Medicines news

We have not published a story on Everest Medicines yet. When there is news, it will appear here.

Questions about Everest Medicines

What is the ticker symbol of Everest Medicines?

Everest Medicines Ltd. trades under the ticker 1952 on HKEX.

Where is Everest Medicines listed?

Everest Medicines Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:6HN; LS:A2QD66; LSX:A2QD66.

Which country or territory is Everest Medicines listed under?

Our directory records Everest Medicines Ltd. under China.

What does Everest Medicines do?

Our directory classifies Everest Medicines Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Everest Medicines?

The ISIN recorded for Everest Medicines Ltd. is KYG3224E1061.

Does aibio.space cover Everest Medicines?

aibio.space lists Everest Medicines Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Everest Medicines?

Companies in our directory listed in the same country and business area as Everest Medicines: ImmuneOnco Biopharmaceuticals (Shanghai), Humanwell Healthcare (Group) Co.,Ltd., JIANMIN PHARMACEUTICAL GROUP CO LTD., Shandong Buchang Pharmaceuticals Co., Zhejiang Hisun Pharmaceutical Co., Shanghai OPM Biosciences Co..

Investor discussion: Everest Medicines

Members talk about Everest Medicines (1952). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Everest Medicines, newest first. Each line links the filing it comes from.

Jun 2, 2026Mergers
Transaction under the Listing Rules: (1) MAJOR AND CONNECTED TRANSACTION ACQUISITION OF THE ENTIRE EQUITY INTEREST IN THE TARGET COMPANY AND ASSIGNMENT OF SHAREHOLDER LOAN; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING. Source
May 29, 2026Mergers
Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR AND BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING. Source
Apr 27, 2026Mergers
Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO THE ASSET PURCHASE AGREEMENT. Source
Apr 7, 2026Mergers
Transaction under the Listing Rules: MAJOR AND CONNECTED TRANSACTION ACQUISITION OF THE ENTIRE EQUITY INTEREST IN THE TARGET COMPANY AND ASSIGNMENT OF SHAREHOLDER LOAN. Source
Mar 22, 2026Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO THE ASSET PURCHASE AGREEMENT. Source
Aug 1, 2025Financings
Share or debt issue: COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source
Jul 24, 2025Financings
Share or debt issue: PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

Press releases

Headlines of Everest Medicines's own announcements, newest first. Each opens the full release on the newswire that carried it.

Sep 28, 2026HKEXnews
TERMS OF REFERENCE OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE
Sep 28, 2026HKEXnews
ESTABLISHMENT OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE
Sep 9, 2026HKEXnews
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE STRATEGIC COOPERATION FRAMEWORK AGREEMENT
Sep 3, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF NEW DRUG APPLICATION IN CHINA FOR CARDAMYST FOR THE CONVERSION OF ACUTE SYMPTOMATIC EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA TO SINUS RHYTHM IN ADULTS
Aug 18, 2026HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026
Aug 14, 2026HKEXnews
CHANGE OF NON-EXECUTIVE DIRECTOR
Jul 17, 2026HKEXnews
GRANT OF OPTIONS AND AWARDS
Jul 7, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT CLOSING OF EXCLUSIVE LICENSE AND COLLABORATION AGREEMENT WITH TRAVERE
Jun 26, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 26 JUNE 2026
Jun 24, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT COMMERCIALIZATION COLLABORATION RELATING TO HAINAN HERUI'S BUDESONIDE ENTERIC CAPSULES
Jun 17, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY SUBSTANTIAL SHAREHOLDER OF THE COMPANY
Jun 17, 2026HKEXnews
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON WEDNESDAY, 17 JUNE 2026
Jun 15, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT AGREEMENT WITH DIMERIX TO DEVELOP AND COMMERCIALIZE DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA
Jun 9, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY SUBSTANTIAL SHAREHOLDER OF THE COMPANY
Jun 7, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT AGREEMENT WITH CORXEL TO DEVELOP AND COMMERCIALIZE LNZ100 IN GREATER CHINA
Jun 2, 2026HKEXnews
Notification Letter to Registered Shareholders - Virtual Meeting Arrangements for the Annual General Meeting
Jun 2, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING
Jun 2, 2026HKEXnews
Notification Letter to Registered Shareholders - Virtual Meeting Arrangements for the Extraordinary General Meeting
Jun 2, 2026HKEXnews
Documents on Display
Jun 2, 2026HKEXnews
NOTICE OF EXTRAORDINARY GENERAL MEETING

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:1952 on TradingView.

Listing details

Company: Everest Medicines Ltd.
Ticker: 1952
Listing: HKEX
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: KYG3224E1061
Other listed symbols: GETTEX:6HN; LS:A2QD66; LSX:A2QD66
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction